New York State Common Retirement Fund
XERS icon

New York State Common Retirement Fund’s Xeris Biopharma Holdings XERS Stock Holding History

New York State Common Retirement Fund’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$425K Buy
53,722
+10,300
+24% +$65.8K ﹤0.01% 2075
2026
Q1 		$252K Hold
43,422
– – ﹤0.01% 2141
2025
Q4 		$341K Hold
43,422
– – ﹤0.01% 2098
2025
Q3 		$353K Hold
43,422
– – ﹤0.01% 2068
2025
Q2 		$203K Hold
43,422
– – ﹤0.01% 2248
2025
Q1 		$238K Buy
43,422
+20,600
+90% +$83.2K ﹤0.01% 2158
2024
Q4 		$77.4K Hold
22,822
– – ﹤0.01% 2700
2024
Q3 		$65K Hold
22,822
– – ﹤0.01% 2776
2024
Q2 		$51.4K Buy
22,822
+38
+0.2% +$77 ﹤0.01% 3081
2024
Q1 		$50.4K Sell
22,784
-91
-0.4% -$235 ﹤0.01% 2980
2023
Q4 		$53.8K Sell
22,875
-260
-1% -$480 ﹤0.01% 2973
2023
Q3 		$43K Buy
23,135
+463
+2% +$1.06K ﹤0.01% 3062
2023
Q2 		$59.4K Sell
22,672
-115
-0.5% -$293 ﹤0.01% 3097
2023
Q1 		$37.1K Sell
22,787
-69,700
-75% -$87.3K ﹤0.01% 3054
2022
Q4 		$123K Sell
92,487
-13
-0% -$18 ﹤0.01% 2903
2022
Q3 		$144K Buy
92,500
+1,100
+1% +$1.82K ﹤0.01% 2894
2022
Q2 		$141K Buy
+91,400
New +$193K ﹤0.01% 2951
2021
Q3 		– Sell
-368
Closed -$1K – 3540
2021
Q2 		$1K Sell
368
-30,389
-99% -$116K ﹤0.01% 3487
2021
Q1 		$139K Buy
30,757
+10,800
+54% +$58.2K ﹤0.01% 2970
2020
Q4 		$98K Buy
19,957
+2,500
+14% +$12.5K ﹤0.01% 3034
2020
Q3 		$104K Hold
17,457
– – ﹤0.01% 2907
2020
Q2 		$46K Hold
17,457
– – ﹤0.01% 3161
2020
Q1 		$34K Hold
17,457
– – ﹤0.01% 3051
2019
Q4 		$123K Sell
17,457
-11,600
-40% -$95.8K ﹤0.01% 2943
2019
Q3 		$286K Buy
29,057
+8,400
+41% +$94.4K ﹤0.01% 2592
2019
Q2 		$236K Buy
20,657
+16,757
+430% +$176K ﹤0.01% 2737
2019
Q1 		$39K Hold
3,900
– – ﹤0.01% 3096
2018
Q4 		$66K Buy
+3,900
New +$78.2K ﹤0.01% 3057

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

New York State Common Retirement Fund's XERS Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Xeris Biopharma Holdings (XERS) stake by 24% in Q2 2026, buying an estimated $65.8K and bringing the position to 53,722 shares worth $425K. The position accounts for ﹤0.01% of the portfolio, ranked #2075.

New York State Common Retirement Fund first reported a position in XERS in Q4 2018 and has held it in 28 quarters since. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • New York State Common Retirement Fund held 53,722 shares of Xeris Biopharma Holdings worth $425K as of Q2 2026.
  • New York State Common Retirement Fund bought 10,300 Xeris Biopharma Holdings shares in Q2 2026, an estimated $65.8K.
  • Xeris Biopharma Holdings made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2075 holding.
  • New York State Common Retirement Fund first reported a position in Xeris Biopharma Holdings in Q4 2018 and has held it in 28 quarters since.
  • 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.